Adenosine-induced apoptosis in glomerular mesangial cells

Zhihui Zhao1, Toros Kapoian, Michelle Shepard

  • 1Nephrology Division, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA.

Kidney International
|March 29, 2002
PubMed
Abstract

Insights

Adenosine (ADO) induces mesangial cell apoptosis through the A3 receptor, a key mechanism in resolving glomerular hypercellularity during kidney inflammation. This finding offers insights into potential therapeutic targets for glomerular diseases.

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Mesangial cell apoptosis resolves glomerular hypercellularity in inflammatory kidney injury.
  • Adenosine (ADO) exhibits anti-inflammatory properties in glomerular diseases.
  • Mesangial cells possess adenosine receptors, suggesting a role for ADO in cell fate.

Purpose of the Study:

  • To investigate whether adenosine induces apoptosis in mesangial cells.
  • To elucidate the underlying molecular mechanisms of adenosine-induced mesangial cell apoptosis.
  • To identify the specific adenosine receptor subtypes involved.

Main Methods:

  • Cultured mouse mesangial cells were treated with adenosine or its receptor agonists/antagonists.
  • Cell viability was assessed using trypan blue exclusion.
  • Apoptosis was quantified via DNA fragmentation, TUNEL staining, and flow cytometry.
  • Adenosine receptor expression was analyzed using RT-PCR and Western blotting.

Main Results:

  • Adenosine and the A3 receptor agonist IB-MECA induced significant mesangial cell death.
  • This cell death was primarily apoptosis and was blocked by the A3 receptor antagonist MRS1191.
  • A1, A2, and A2a receptor agonists did not induce apoptosis.
  • Mesangial cells expressed A3, A1, and A2b receptor transcripts, but only A3 receptor protein was detected.
  • The apoptotic pathway was independent of cyclic AMP (cAMP).

Conclusions:

  • Adenosine induces mesangial cell apoptosis predominantly through the activation of the A3 receptor.
  • This mechanism is crucial for the resolution of glomerular hypercellularity.
  • The findings highlight the A3 adenosine receptor as a potential therapeutic target in inflammatory glomerular diseases.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K